|
Volumn 3, Issue 4, 2005, Pages 789-790
|
The use of LMWH in pregnancies at risk: New evidence or perception?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTIINFLAMMATORY AGENT;
BLOOD CLOTTING FACTOR 5 LEIDEN;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
HEPARINOID;
HIRUDIN;
HOMOCYSTEINE;
LOW MOLECULAR WEIGHT HEPARIN;
PHOSPHOLIPID ANTIBODY;
PLACEBO;
WATER;
AMENORRHEA;
ANTIPHOSPHOLIPID SYNDROME;
BLEEDING;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG RESEARCH;
FETUS WASTAGE;
GENE MUTATION;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
META ANALYSIS;
NONHUMAN;
OSTEOPOROSIS;
PREGNANCY;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
REVIEW;
SCREENING;
SKIN MANIFESTATION;
SPONTANEOUS ABORTION;
SYSTEMATIC REVIEW;
THROMBOPHILIA;
THROMBOSIS;
THROMBOSIS PREVENTION;
VENOUS THROMBOEMBOLISM;
CLINICAL PROTOCOL;
FEMALE;
HIGH RISK PREGNANCY;
NOTE;
PREGNANCY OUTCOME;
RECURRENT ABORTION;
RISK FACTOR;
STANDARD;
ABORTION, HABITUAL;
ABORTION, SPONTANEOUS;
ANTICOAGULANTS;
CLINICAL PROTOCOLS;
FEMALE;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
PREGNANCY;
PREGNANCY COMPLICATIONS, HEMATOLOGIC;
PREGNANCY OUTCOME;
PREGNANCY, HIGH-RISK;
RISK FACTORS;
THROMBOPHILIA;
|
EID: 23044432672
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2005.01286.x Document Type: Review |
Times cited : (32)
|
References (0)
|